A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy

Año publicación: 2024

Subir documento: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15875

Nombre investigadores: Filip K Knop, Shweta Urva, Mallikarjuna Rettiganti, Charles T Benson, William C Roell, Kieren J Mather, Axel Haupt, Edward John Pratt